News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Vignola Mark J.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/02/2023 |
4
| Vignola Mark J. (CFO) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 9,997 shares
@ $1.41, valued at
$14.1k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Vignola Mark J. (CFO) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Bought 7,656 shares
@ $1.47, valued at
$11.3k
|
|
| 01/28/2022 |
4
| Vignola Mark J. (CFO) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Granted 65,000 options to buy
@ $5.36, valued at
$348.4k
|
|
| 09/30/2021 |
4
| Vignola Mark J. (CFO) has filed a Form 4 on Terns Pharmaceuticals, Inc.|
Txns:
| Granted 120,000 options to buy
@ $10.72, valued at
$1.3M
|
|
| 02/04/2021 |
3
| Vignola Mark J. (CFO) has filed a Form 3 on Terns Pharmaceuticals, Inc. |
| 05/15/2019 |
4
| Vignola Mark J. (CFO) has filed a Form 4 on Applied Therapeutics Inc.|
Txns:
| Granted 34,104 options to buy
@ $10, valued at
$341k
|
|
| 05/13/2019 |
3
| Vignola Mark J. (CFO) has filed a Form 3 on Applied Therapeutics Inc. |
|
|